GB9923933D0 - Novel pharmaceutical - Google Patents

Novel pharmaceutical

Info

Publication number
GB9923933D0
GB9923933D0 GBGB9923933.7A GB9923933A GB9923933D0 GB 9923933 D0 GB9923933 D0 GB 9923933D0 GB 9923933 A GB9923933 A GB 9923933A GB 9923933 D0 GB9923933 D0 GB 9923933D0
Authority
GB
United Kingdom
Prior art keywords
novel pharmaceutical
pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9923933.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Laboratoires Pharmaceutiques
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Laboratoires Pharmaceutiques
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Laboratoires Pharmaceutiques, SmithKline Beecham Ltd filed Critical SmithKline Beecham Laboratoires Pharmaceutiques
Priority to GBGB9923933.7A priority Critical patent/GB9923933D0/en
Publication of GB9923933D0 publication Critical patent/GB9923933D0/en
Priority to IL14896600A priority patent/IL148966A0/xx
Priority to EP00964535A priority patent/EP1218334A1/en
Priority to BR0014591-2A priority patent/BR0014591A/pt
Priority to CZ20021189A priority patent/CZ20021189A3/cs
Priority to PCT/GB2000/003847 priority patent/WO2001027071A1/en
Priority to JP2001530092A priority patent/JP2003511437A/ja
Priority to TR2002/00949T priority patent/TR200200949T2/xx
Priority to MXPA02003516A priority patent/MXPA02003516A/es
Priority to CA002386845A priority patent/CA2386845A1/en
Priority to CN00813990A priority patent/CN1384817A/zh
Priority to AU75460/00A priority patent/AU7546000A/en
Priority to HU0203582A priority patent/HUP0203582A2/hu
Priority to KR1020027004451A priority patent/KR20020043618A/ko
Priority to PL00354137A priority patent/PL354137A1/xx
Priority to NO20021639A priority patent/NO20021639L/no
Priority to ZA200202679A priority patent/ZA200202679B/en
Priority to HK02109370.9A priority patent/HK1049147A1/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB9923933.7A 1999-10-08 1999-10-08 Novel pharmaceutical Ceased GB9923933D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB9923933.7A GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical
PL00354137A PL354137A1 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride
MXPA02003516A MXPA02003516A (es) 1999-10-08 2000-10-06 Clorihidrato de n-[3-[[2-(3,4-dimetoxifenil)etil]amino[propil]-4-nitrobenzamida polimorfico.
CN00813990A CN1384817A (zh) 1999-10-08 2000-10-06 多晶型的n－[3－[[2－(3,4－二甲氧基苯基)乙基]氨基]丙基]－4－硝基苯甲酰胺盐酸化物
BR0014591-2A BR0014591A (pt) 1999-10-08 2000-10-06 Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida
CZ20021189A CZ20021189A3 (cs) 1999-10-08 2000-10-06 Polymorfní N-[3-[[2-(3,4-dimethoxyfenyl)ethyl]amino]propyl]-4-nitrobenzamid-hydrochlorid
PCT/GB2000/003847 WO2001027071A1 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride
JP2001530092A JP2003511437A (ja) 1999-10-08 2000-10-06 Ｎ−［３−［［２−（３，４−ジメトキシフェニル）エチル］アミノ］プロピル］−４−ニトロベンズアミド塩酸塩の多型相
TR2002/00949T TR200200949T2 (tr) 1999-10-08 2000-10-06 Polimorfik N-[3-[[2-(3,4-dimetoksifenil)etil]amino]propil]-4-nitro benzamid hidroklorid
IL14896600A IL148966A0 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyp ethyl]amino]propyl]-4-nitro benzamide hydrochloride
CA002386845A CA2386845A1 (en) 1999-10-08 2000-10-06 Polymorphic n-¬3-¬¬2-(3,4-dimethoxyphenyl) ethyl| amino| propyl| -4-nitro benzamide hydrochloride
EP00964535A EP1218334A1 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]- 4-nitro benzamide hydrochloride
AU75460/00A AU7546000A (en) 1999-10-08 2000-10-06 Polymorphic N-(3-((2-(3,4-dimethoxyphenyl) ethyl) amino) propyl) -4-nitro benzamide hydrochloride
HU0203582A HUP0203582A2 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-{[2-(3,4-dimethoxyphenyl)ethyl]amino}propyl]-4-nitro benzamide hydrochloride, process for its preparation, pharmaceutical composition comprising thereof and its use
KR1020027004451A KR20020043618A (ko) 1999-10-08 2000-10-06 Ｎ-[3-[[2-(3,4-디메톡시페닐)에틸]아미노]프로필]-4-니트로벤즈아미드 히드로클로라이드의 다형태
ZA200202679A ZA200202679B (en) 1999-10-08 2002-04-05 Polymorphic N-[3-[[2-(3, 4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro benzamide hydrochloride.
NO20021639A NO20021639L (no) 1999-10-08 2002-04-05 Polymorft N-[3-[[2-(3,4-dimetoksyfenyl)etyl]amino]propyl]-4- nitrobenzamid hydroklorid
HK02109370.9A HK1049147A1 (zh) 1999-10-08 2002-12-27 多形態的n-[3-[[2-(3，4-二甲氧基苯)乙基]氨基]炳基]-4-含硝基的苯甲酰胺鹽酸鹽

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9923933.7A GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
GB9923933D0 true GB9923933D0 (en) 1999-12-08

Family

ID=10862442

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9923933.7A Ceased GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical

Country Status (18)

Country Link
EP (1) EP1218334A1 (zh)
JP (1) JP2003511437A (zh)
KR (1) KR20020043618A (zh)
CN (1) CN1384817A (zh)
AU (1) AU7546000A (zh)
BR (1) BR0014591A (zh)
CA (1) CA2386845A1 (zh)
CZ (1) CZ20021189A3 (zh)
GB (1) GB9923933D0 (zh)
HK (1) HK1049147A1 (zh)
HU (1) HUP0203582A2 (zh)
IL (1) IL148966A0 (zh)
MX (1) MXPA02003516A (zh)
NO (1) NO20021639L (zh)
PL (1) PL354137A1 (zh)
TR (1) TR200200949T2 (zh)
WO (1) WO2001027071A1 (zh)
ZA (1) ZA200202679B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272501B1 (en) * 2002-01-09 2013-03-20 Emisphere Technologies, Inc. Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
PT2091910E (pt) * 2006-12-06 2014-11-18 Conatus Pharmaceuticals Inc Formas cristalinas do ácido (3s)-3-[n-(n¿-(2-tercbutilfenil) oxamil)alaninil]amino-5-(2¿,3¿,5¿,6¿- tetrafluorofenoxi)-4-oxopentanóico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
GB9706376D0 (en) * 1997-03-27 1997-05-14 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
PL354137A1 (en) 2003-12-29
WO2001027071A1 (en) 2001-04-19
JP2003511437A (ja) 2003-03-25
EP1218334A1 (en) 2002-07-03
CA2386845A1 (en) 2001-04-19
CZ20021189A3 (cs) 2002-09-11
NO20021639L (no) 2002-05-30
MXPA02003516A (es) 2004-09-10
ZA200202679B (en) 2003-05-28
BR0014591A (pt) 2002-06-11
CN1384817A (zh) 2002-12-11
IL148966A0 (en) 2002-11-10
NO20021639D0 (no) 2002-04-05
KR20020043618A (ko) 2002-06-10
HK1049147A1 (zh) 2003-05-02
TR200200949T2 (tr) 2002-08-21
HUP0203582A2 (en) 2004-03-01
AU7546000A (en) 2001-04-23

Similar Documents

Publication Publication Date Title
PL351387A1 (en) Pharmaceutical composition
GB0006133D0 (en) Novel pharmaceutical
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
EG23858A (en) Drug combination
EG23937A (en) Novel pharmaceutical
IL145632A0 (en) Pharmaceutical compounds
GB9916434D0 (en) Pharmaceutical compounds
PL351135A1 (en) Novel pharmaceutical
GB9914255D0 (en) Pharmaceutical compounds
IL146341A0 (en) Pharmaceutical complex
GB9903784D0 (en) Pharmaceutical compounds
EG23946A (en) Novel pharmaceutical
GB2373499B (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB9923933D0 (en) Novel pharmaceutical
GB9923934D0 (en) Novel pharmaceutical
GB0019223D0 (en) Novel pharmaceutical
GB9912196D0 (en) Novel pharmaceutical
GB9912195D0 (en) Novel pharmaceutical
GB9912197D0 (en) Novel pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9926434D0 (en) Pharmaceutical
SI1252133T1 (en) Pharmaceutical compounds
SI1169298T1 (sl) Framacevtske spojine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)